Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Biotechnology
  4. Fast Track Articles
  5. Fast Track Article
image of Bridging the GAP: Probiotic Douches Redefining the Feminine Hygiene

Abstract

Vaginal douching is a centuries-old practice which is still in use, especially among adolescents. “Probiotic douches” are the vaginal douches that are formulated with probiotics and are intended to restore or maintain the vaginal microbiome balance. Probiotic douches are a new type of feminine hygiene product that claims to promote a balanced vaginal microbiome and improve overall well-being. However, the evidence supporting the use of probiotics for vaginal health is limited because of the variability in probiotic strains and dosages studied, and the lack of more comprehensive, long-term clinical trials. Most of the existing scientific literature on probiotics focuses on oral probiotic supplements and vaginal probiotic suppositories. Some potential benefits of probiotic douches include restoring a balanced vaginal microbiota, preventing, or managing infections, supporting local immune function, reducing odor and discharge, and enhancing overall vaginal comfort. However, it is important to note that these benefits have not been definitively proven and remain a subject of ongoing research. There are also potential risks associated with their use including disruption of the natural vaginal ecosystem by introducing foreign substances, risk of infection, and stability issues with the formulation that may lead to negative consequences. This review attempts to comprehend the critical need for robust scientific research to guide the safe and effective incorporation of probiotic douches into modern feminine hygiene practices, revolutionizing women's health, and well-being.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010322564240929204907
2024-10-09
2024-11-20

  • From This Site

    /content/journals/cpb/10.2174/0113892010322564240929204907
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Aral S.O. Mosher W.D. Cates W. Jr Vaginal douching among women of reproductive age in the United States: 1988. Am. J. Public Health 1992 82 2 210 214 10.2105/AJPH.82.2.210 1739149
    [Google Scholar]
  2. Monif G.R.G. The great douching debate: To douche, or not to douche. Obstet. Gynecol. 1999 94 4 630 631 10.1097/00006250‑199910000‑00027 10511372
    [Google Scholar]
  3. Anger J. Lee U. Ackerman A.L. Chou R. Chughtai B. Clemens J.Q. Hickling D. Kapoor A. Kenton K.S. Kaufman M.R. Rondanina M.A. Stapleton A. Stothers L. Chai T.C. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J. Urol. 2019 202 2 282 289 10.1097/JU.0000000000000296 31042112
    [Google Scholar]
  4. Puebla-Barragan S. Reid G. Probiotics in cosmetic and personal care products: Trends and challenges. Molecules 2021 26 5 1249 10.3390/molecules26051249 33652548
    [Google Scholar]
  5. Mashatan N. Heidari R. Altafi M. Amiri A. Ommati M.M. Hashemzaei M. Probiotics in vaginal health. Pathog. Dis. 2023 81 ftad012 10.1093/femspd/ftad012 37286796
    [Google Scholar]
  6. Cribby S Taylor M Reid G Vaginal microbiota and the use of probiotics. Interdiscip. Perspect. Infect. Dis. 2008 2008 256490 10.1155/2008/256490
    [Google Scholar]
  7. Lin Y.P. Chen W.C. Cheng C.M. Shen C.J. Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics 2021 11 11 1996 10.3390/diagnostics11111996 34829343
    [Google Scholar]
  8. Chee W.J.Y. Chew S.Y. Than L.T.L. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb. Cell Fact. 2020 19 1 203 10.1186/s12934‑020‑01464‑4 33160356
    [Google Scholar]
  9. Kim J.M. Park Y.J. Probiotics in the prevention and treatment of postmenopausal vaginal infections. J. Menopausal Med. 2017 23 3 139 145 10.6118/jmm.2017.23.3.139 29354612
    [Google Scholar]
  10. Fashemi B. Delaney M.L. Onderdonk A.B. Fichorova R.N. Effects of feminine hygiene products on the vaginal mucosal biome. Microb. Ecol. Health Dis. 2013 24 1 19703 24009546
    [Google Scholar]
  11. Zuzelo P.R. Holistic care for women includes addressing vaginal health. Holist. Nurs. Pract. 2017 31 2 137 139 10.1097/HNP.0000000000000202 28181980
    [Google Scholar]
  12. redondo-Lopez V. Cook R.L. Sobel J.D. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Clin. Infect. Dis. 1990 12 5 856 872 10.1093/clinids/12.5.856 2237129
    [Google Scholar]
  13. Konings W. Kok J. Kuipers O.P. Poolman B. Lactic acid bacteria: The bugs of the new millennium. Curr. Opin. Microbiol. 2000 3 3 276 282 10.1016/S1369‑5274(00)00089‑8 10851157
    [Google Scholar]
  14. Reid G. Probiotic Lactobacilli for urogenital health in women. J. Clin. Gastroenterol. 2008 42 Suppl. 3 S234 S236 10.1097/MCG.0b013e31817f1298 18685506
    [Google Scholar]
  15. Reid G. Charbonneau D. Erb J. Kochanowski B. Beuerman D. Poehner R. Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 2003 35 2 131 134 10.1016/S0928‑8244(02)00465‑0 12628548
    [Google Scholar]
  16. Ravel J. Gajer P. Abdo Z. Schneider G.M. Koenig S.S.K. McCulle S.L. Karlebach S. Gorle R. Russell J. Tacket C.O. Brotman R.M. Davis C.C. Ault K. Peralta L. Forney L.J. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 2011 108 Suppl 1 Suppl. 1 4680 4687 10.1073/pnas.1002611107 20534435
    [Google Scholar]
  17. Morton A.M. Freedom from worry: Douching as a case study for historical archaeological approaches to women’s health. University of Idaho 2013
    [Google Scholar]
  18. Abma J.C. Chandra A. Mosher W.D. Peterson L.S. Piccinino L.J. Fertility, family planning, and women's health: New data from the 1995 national survey of family growth. Vital Health Stat 23 1997 19 1 114
    [Google Scholar]
  19. Key statistics from the National Survey of Family Growth—I listing. Available from: https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm
  20. Merchant J.S. Oh M.K. Klerman L.V. Douching. Arch. Pediatr. Adolesc. Med. 1999 153 8 834 837 10.1001/archpedi.153.8.834 10437756
    [Google Scholar]
  21. Cottrell B.H. An updated review of of evidence to discourage douching. MCN Am. J. Matern. Child Nurs. 2010 35 2 102 107 10.1097/NMC.0b013e3181cae9da 20215951
    [Google Scholar]
  22. Foch B.J. McDaniel N.D. Chacko M.R. Racial differences in vaginal douching knowledge, attitude, and practices among sexually active adolescents. J. Pediatr. Adolesc. Gynecol. 2001 14 1 29 33 10.1016/S1083‑3188(00)00080‑2 11358704
    [Google Scholar]
  23. Vermund S.H. Sarr M. Murphy D.A. Levin L. Abdalian S.E. Ma Y. Crowley-Nowick P.A. Wilson C.M. Adolescent Medicine HIV/AIDS Research Network Douching practices among HIV infected and uninfected adolescents in the United States. J. Adolesc. Health 2001 29 3 Suppl. 80 86 10.1016/S1054‑139X(01)00284‑1 11530307
    [Google Scholar]
  24. Oh M.K. Merchant J.S. Brown P. Douching behavior in high-risk adolescents. What do they use, when and why do they douche? J. Pediatr. Adolesc. Gynecol. 2002 15 2 83 88 10.1016/S1083‑3188(01)00148‑6 12057529
    [Google Scholar]
  25. Blythe M.J. Fortenberry J.D. Orr D.P. Douching behaviors reported by adolescent and young adult women at high risk for sexually transmitted infections. J. Pediatr. Adolesc. Gynecol. 2003 16 2 95 100 10.1016/S1083‑3188(03)00027‑5 12742144
    [Google Scholar]
  26. Oh M. Simpson T. Vazin T. Spivey C. Brown P. Davies S. Scissumgunn K. Vaginal douching and reproductive health protection practices of university students. J. Adolesc. Health 2004 34 2 147 10.1016/S1054‑139X(03)00457‑9
    [Google Scholar]
  27. Gupta S. Kakkar V. Bhushan I. Crosstalk between vaginal microbiome and female health: A review. Microb. Pathog. 2019 136 103696 10.1016/j.micpath.2019.103696 31449855
    [Google Scholar]
  28. Bolton M. van der Straten A. Cohen C.R. Probiotics: Potential to prevent HIV and sexually transmitted infections in women. Sex. Transm. Dis. 2008 35 3 214 225 10.1097/OLQ.0b013e31815b017a 18490864
    [Google Scholar]
  29. Bertini M Serdaroglu S Kutlubay Z Bacterial vaginosis and sexually transmitted diseases: Relationship and management. Fundamentals of Sexually Transmitted Infections. InTech 2017 10.5772/intechopen.69258
    [Google Scholar]
  30. Schwebke J.R. Role of vaginal flora as a barrier to HIV acquisition. Curr. Infect. Dis. Rep. 2001 3 2 152 155 10.1007/s11908‑996‑0040‑6 11286657
    [Google Scholar]
  31. Farage MA Miller KW Sobel JD Dynamics of the vaginal ecosystem—hormonal influences. Infect. Dis. Res. Treat. 2010 3 S3903
    [Google Scholar]
  32. Reid G. Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am. J. Obstet. Gynecol. 2003 189 4 1202 1208 10.1067/S0002‑9378(03)00495‑2 14586379
    [Google Scholar]
  33. Dover S.E. Aroutcheva A.A. Faro S. Chikindas M.L. Natural antimicrobials and their role in vaginal health: A short review. Int. J. Probiotics Prebiotics 2008 3 4 219 230 20657710
    [Google Scholar]
  34. Rampersaud R. Randis T.M. Ratner A.J. Microbiota of the upper and lower genital tract. Seminars in Fetal and Neonatal Medicine. Elsevier 2012
    [Google Scholar]
  35. Gupta V. Garg R. Probiotics. Indian J. Med. Microbiol. 2009 27 3 202 209 10.4103/0255‑0857.53201 19584499
    [Google Scholar]
  36. Anukam K. Osazuwa E. Ahonkhai I. Ngwu M. Osemene G. Bruce A.W. Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect. 2006 8 6 1450 1454 10.1016/j.micinf.2006.01.003 16697231
    [Google Scholar]
  37. Beerepoot M.A.J. ter Riet G. Nys S. van der Wal W.M. de Borgie C.A. de Reijke T.M. Prins J.M. Koeijers J. Verbon A. Stobberingh E. Geerlings S.E. Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women. Arch. Intern. Med. 2012 172 9 704 712 10.1001/archinternmed.2012.777 22782199
    [Google Scholar]
  38. Donders G.G.G. Vereecken A. Bosmans E. Dekeersmaecker A. Salembier G. Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: Aerobic vaginitis. BJOG 2002 109 1 34 43 10.1111/j.1471‑0528.2002.00432.x 11845812
    [Google Scholar]
  39. Jahic M. Mulavdic M. Nurkic J. Jahic E. Nurkic M. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis. Med. Arh. 2013 67 6 428 430 10.5455/medarh.2013.67.428‑430 25568514
    [Google Scholar]
  40. Peebles K. Velloza J. Balkus J.E. McClelland R.S. Barnabas R.V. High global burden and costs of bacterial vaginosis: A systematic review and meta-analysis. Sex. Transm. Dis. 2019 46 5 304 311 10.1097/OLQ.0000000000000972 30624309
    [Google Scholar]
  41. Coudray M.S. Madhivanan P. Bacterial vaginosis—A brief synopsis of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020 245 143 148 10.1016/j.ejogrb.2019.12.035 31901667
    [Google Scholar]
  42. Vodstrcil L.A. Muzny C.A. Plummer E.L. Sobel J.D. Bradshaw C.S. Bacterial vaginosis: Drivers of recurrence and challenges and opportunities in partner treatment. BMC Med. 2021 19 1 194 10.1186/s12916‑021‑02077‑3 34470644
    [Google Scholar]
  43. Makanjuola O. Bongomin F. Fayemiwo S. An update on the roles of non-albicans Candida species in vulvovaginitis. J. Fungi 2018 4 4 121 10.3390/jof4040121 30384449
    [Google Scholar]
  44. Sobel J.D. 53 - Vaginitis, vulvitis, cervicitis and cutaneous vulval lesions. Infectious Diseases. 4th ed Cohen J. Powderly W.G. Opal S.M. Elsevier 2017 483 91.e1 10.1016/B978‑0‑7020‑6285‑8.00053‑8
    [Google Scholar]
  45. Szybala M.P. Szybala C. 224 - Vaginitis, Vulvovaginitis, and Vulvodynia. Textbook of Natural Medicine. 5th ed Pizzorno J.E. Murray M.T. St. Louis, MO Churchill Livingstone 2020 1840 9.e4 10.1016/B978‑0‑323‑43044‑9.00224‑7
    [Google Scholar]
  46. Rao V.L. Mahmood T. Vaginal discharge. Obstetrics, Gynaecol. Reprod. Med. 2020 30 1 11 18 10.1016/j.ogrm.2019.10.004
    [Google Scholar]
  47. Tine RC Sylla K Ka R Dia L Sow D Lelo S A study of Trichomonas vaginalis infection and correlates in women with vaginal discharge referred at Fann Teaching Hospital in Senegal. J. Parasitol. Res. 2019 2019
    [Google Scholar]
  48. Silver B.J. Guy R.J. Kaldor J.M. Jamil M.S. Rumbold A.R. Trichomonas vaginalis as a cause of perinatal morbidity: A systematic review and meta-analysis. Sex. Transm. Dis. 2014 41 6 369 376 10.1097/OLQ.0000000000000134 24825333
    [Google Scholar]
  49. Daskalakis G. Psarris A. Koutras A. Fasoulakis Z. Prokopakis I. Varthaliti A. Karasmani C. Ntounis T. Domali E. Theodora M. Antsaklis P. Pappa K.I. Papapanagiotou A. Maternal infection and preterm birth: From molecular basis to clinical implications. Children 2023 10 5 907 10.3390/children10050907 37238455
    [Google Scholar]
  50. Cotch M.F. Pastorek J.G. II Nugent R.P. Hillier S.L. Gibbs R.S. Martin D.H. Eschenbach D.A. Edelman R. Carey C.J. Regan J.A. Krohn M.A. Klebanoff M.A. Rao V.A. Rhoads G.G. The Vaginal Infections and Prematurity Study Group Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 1997 24 6 353 360 10.1097/00007435‑199707000‑00008 9243743
    [Google Scholar]
  51. Chiu S.F. Huang P.J. Cheng W.H. Huang C.Y. Chu L.J. Lee C.C. Lin H.C. Chen L.C. Lin W.N. Tsao C.H. Tang P. Yeh Y.M. Huang K.Y. Vaginal microbiota of the sexually transmitted infections caused by Chlamydia trachomatis and Trichomonas vaginalis in women with vaginitis in Taiwan. Microorganisms 2021 9 9 1864 10.3390/microorganisms9091864 34576759
    [Google Scholar]
  52. Van Gerwen O.T. Muzny C.A. Marrazzo J.M. Sexually transmitted infections and female reproductive health. Nat. Microbiol. 2022 7 8 1116 1126 10.1038/s41564‑022‑01177‑x 35918418
    [Google Scholar]
  53. Zhang Z.F. Graham S. Yu S.Z. Marshall J. Zielezny M. Chen Y.X. Sun M. Tang S.L. Liao C.S. Xu J.L. Yang X-Z. Trichomonas vaginalis and cervical cancer. Ann. Epidemiol. 1995 5 4 325 332 10.1016/1047‑2797(94)00101‑X 8520717
    [Google Scholar]
  54. Kudela E. Liskova A. Samec M. Koklesova L. Holubekova V. Rokos T. Kozubik E. Pribulova T. Zhai K. Busselberg D. Kubatka P. Biringer K. The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer. EPMA J. 2021 12 2 199 220 10.1007/s13167‑021‑00244‑3 34194585
    [Google Scholar]
  55. Cudmore S.L. Garber G.E. Prevention or treatment: The benefits of Trichomonas vaginalis vaccine. J. Infect. Public Health 2010 3 2 47 53 10.1016/j.jiph.2010.01.003 20701891
    [Google Scholar]
  56. Mirzadeh M. Olfatifar M. Eslahi A.V. Abdoli A. Houshmand E. Majidiani H. Johkool M.G. Askari S. Hashemipour S. Badri M. Global prevalence of Trichomonas vaginalis among female sex workers: A systematic review and meta-analysis. Parasitol. Res. 2021 120 7 2311 2322 10.1007/s00436‑021‑07216‑6 34170387
    [Google Scholar]
  57. Palma E. Recine N. Domenici L. Giorgini M. Pierangeli A. Panici P.B. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: A promising solution against HPV-infection. BMC Infect. Dis. 2018 18 1 13 10.1186/s12879‑017‑2938‑z 29304768
    [Google Scholar]
  58. Borges S. Silva J. Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch. Gynecol. Obstet. 2014 289 3 479 489 10.1007/s00404‑013‑3064‑9 24170161
    [Google Scholar]
  59. Strus M. Kucharska A. Kukla G. Brzychczy-Włoch M. Maresz K. Heczko P.B. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect. Dis. Obstet. Gynecol. 2005 13 2 69 75 10.1080/10647440400028136 16011996
    [Google Scholar]
  60. O’Hanlon D.E. Moench T.R. Cone R.A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 2011 11 1 200 10.1186/1471‑2334‑11‑200 21771337
    [Google Scholar]
  61. Charlier C. Cretenet M. Even S. Le Loir Y. Interactions between Staphylococcus aureus and lactic acid bacteria: An old story with new perspectives. Int. J. Food Microbiol. 2009 131 1 30 39 10.1016/j.ijfoodmicro.2008.06.032 18687499
    [Google Scholar]
  62. Reid G. Kim S.O. Köhler G.A. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol. Med. Microbiol. 2006 46 2 149 157 10.1111/j.1574‑695X.2005.00026.x 16487295
    [Google Scholar]
  63. Hickey R.J. Zhou X. Pierson J.D. Ravel J. Forney L.J. Understanding vaginal microbiome complexity from an ecological perspective. Transl. Res. 2012 160 4 267 282 10.1016/j.trsl.2012.02.008 22683415
    [Google Scholar]
  64. Conti C. Malacrino C. Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J. Physiol. Pharmacol. 2009 60 Suppl. 6 19 26 20224147
    [Google Scholar]
  65. Nardis C. Mosca L. Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann. Ig. 2013 25 5 443 456 24048183
    [Google Scholar]
  66. Lin Q. Lim J.Y.C. Xue K. Yew P.Y.M. Owh C. Chee P.L. Loh X.J. Sanitizing agents for virus inactivation and disinfection. VIEW 2020 1 2 e16 10.1002/viw2.16 34766164
    [Google Scholar]
  67. Kim Y Kim C Cho M Na J Song T Oh J. Hydrogen peroxide-producing Lactobacilli in the vaginal flora of pregnant women with preterm labor with intact membranes. Int. J. Gynecol. Obstet. 2006 93 1 22 27
    [Google Scholar]
  68. Muench D.F. Kuch D.J. Wu H. Begum A.A. Veit S.J. Pelletier M.E. Soler-García Á.A. Jerse A.E. Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection. J. Infect. Dis. 2009 199 9 1369 1378 10.1086/597390 19301977
    [Google Scholar]
  69. Gillor O. Nigro L. Riley M. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. Curr. Pharm. Des. 2005 11 8 1067 1075 10.2174/1381612053381666 15777256
    [Google Scholar]
  70. Cotter P.D. Hill C. Ross R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 2005 3 10 777 788 10.1038/nrmicro1273 16205711
    [Google Scholar]
  71. Riley M.A. Wertz J.E. Bacteriocins: Evolution, ecology, and application. Annu. Rev. Microbiol. 2002 56 1 117 137 10.1146/annurev.micro.56.012302.161024 12142491
    [Google Scholar]
  72. Rea M.C. Dobson A. O’Sullivan O. Crispie F. Fouhy F. Cotter P.D. Shanahan F. Kiely B. Hill C. Ross R.P. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. USA 2011 108 Suppl 1 Suppl. 1 4639 4644 10.1073/pnas.1001224107 20616009
    [Google Scholar]
  73. Corsetti A. Settanni L. Lactobacilli in sourdough fermentation. Food Res. Int. 2007 40 5 539 558 10.1016/j.foodres.2006.11.001
    [Google Scholar]
  74. Drider D. Rebuffat S. Prokaryotic antimicrobial peptides: From genes to applications. Springer Science & Business Media 2011 10.1007/978‑1‑4419‑7692‑5
    [Google Scholar]
  75. Golowczyc M.A. Gugliada M.J. Hollmann A. Delfederico L. Garrote G.L. Abraham A.G. Semorile L. De Antoni G. Characterization of homofermentative lactobacilli isolated from kefir grains: Potential use as probiotic. J. Dairy Res. 2008 75 2 211 217 10.1017/S0022029908003117 18474139
    [Google Scholar]
  76. Ocaña V.S. Pesce de Ruiz Holgado A.A. Nader-Macías M.E. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Environ. Microbiol. 1999 65 12 5631 5635 10.1128/AEM.65.12.5631‑5635.1999 10584033
    [Google Scholar]
  77. Aroutcheva A. Gariti D. Simon M. Shott S. Faro J. Simoes J.A. Gurguis A. Faro S. Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol. 2001 185 2 375 379 10.1067/mob.2001.115867 11518895
    [Google Scholar]
  78. Pascual L.M. Daniele M.B. Giordano W. Pájaro M.C. Barberis I.L. Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr. Microbiol. 2008 56 4 397 402 10.1007/s00284‑007‑9094‑4 18172715
    [Google Scholar]
  79. Vera Pingitore E. Hébert E.M. Nader-Macías M.E. Sesma F. Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina. Res. Microbiol. 2009 160 6 401 408 10.1016/j.resmic.2009.06.009 19591924
    [Google Scholar]
  80. Dezwaan D.C. Mequio M.J. Littell J.S. Allen J.P. Rossbach S. Pybus V. Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis. Microb. Ecol. Health Dis. 2007 19 4 241 250 19578555
    [Google Scholar]
  81. Godha K. Tucker K.M. Biehl C. Archer D.F. Mirkin S. Human vaginal pH and microbiota: An update. Gynecol. Endocrinol. 2018 34 6 451 455 10.1080/09513590.2017.1407753 29271266
    [Google Scholar]
  82. Linhares IM Summers PR Larsen B Giraldo PC Witkin SS Contemporary perspectives on vaginal pH and lactobacilli. Am. J. Obstet. Gynecol. 2011 204 2 120 10.1016/j.ajog.2010.07.010
    [Google Scholar]
  83. Boskey E.R. Telsch K.M. Whaley K.J. Moench T.R. Cone R.A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 1999 67 10 5170 5175 10.1128/IAI.67.10.5170‑5175.1999 10496892
    [Google Scholar]
  84. Vaneechoutte M. The human vaginal microbial community. Res. Microbiol. 2017 168 9-10 811 825 10.1016/j.resmic.2017.08.001 28851670
    [Google Scholar]
  85. Tachedjian G. Aldunate M. Bradshaw C.S. Cone R.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 2017 168 9-10 782 792 10.1016/j.resmic.2017.04.001 28435139
    [Google Scholar]
  86. Coudeyras S Jugie G Vermerie M Forestier C Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect. Dis. Obstet. Gynecol. 2008 2008
    [Google Scholar]
  87. Kudelka M.R. Stowell S.R. Cummings R.D. Neish A.S. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat. Rev. Gastroenterol. Hepatol. 2020 17 10 597 617 10.1038/s41575‑020‑0331‑7 32710014
    [Google Scholar]
  88. Moran A.P. Gupta A. Joshi L. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 2011 60 10 1412 1425 10.1136/gut.2010.212704 21228430
    [Google Scholar]
  89. Boris S. Suárez J.E. Vázquez F. Barbés C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 1998 66 5 1985 1989 10.1128/IAI.66.5.1985‑1989.1998 9573080
    [Google Scholar]
  90. Pascual L.M. Daniele M.B. Ruiz F. Giordano W. Pájaro C. Barberis L. Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina. J. Gen. Appl. Microbiol. 2008 54 3 141 148 10.2323/jgam.54.141 18654035
    [Google Scholar]
  91. Turroni F. Ventura M. Buttó L.F. Duranti S. O’Toole P.W. Motherway M.O.C. van Sinderen D. Molecular dialogue between the human gut microbiota and the host: A Lactobacillus and Bifidobacterium perspective. Cell. Mol. Life Sci. 2014 71 2 183 203 10.1007/s00018‑013‑1318‑0 23516017
    [Google Scholar]
  92. Russo R. Karadja E. De Seta F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: A double blind, placebo controlled, randomised clinical trial. Benef. Microbes 2019 10 1 19 26 10.3920/BM2018.0075 30525953
    [Google Scholar]
  93. Mastromarino P. Macchia S. Meggiorini L. Trinchieri V. Mosca L. Perluigi M. Midulla C. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin. Microbiol. Infect. 2009 15 1 67 74 10.1111/j.1469‑0691.2008.02112.x 19046169
    [Google Scholar]
  94. Mei Z. Li D. The role of probiotics in vaginal health. Front. Cell. Infect. Microbiol. 2022 12 963868 10.3389/fcimb.2022.963868 35967876
    [Google Scholar]
  95. Martino J.L. Vermund S.H. Vaginal douching: Evidence for risks or benefits to women’s health. Epidemiol. Rev. 2002 24 2 109 124 10.1093/epirev/mxf004 12762087
    [Google Scholar]
  96. Hesham H. Mitchell A.J. Bergerat A. Hung K. Mitchell C.M. Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses. Sci. Rep. 2021 11 1 23069 10.1038/s41598‑021‑02426‑5 34845288
    [Google Scholar]
  97. Swanson K.S. Gibson G.R. Hutkins R. Reimer R.A. Reid G. Verbeke K. Scott K.P. Holscher H.D. Azad M.B. Delzenne N.M. Sanders M.E. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 2020 17 11 687 701 10.1038/s41575‑020‑0344‑2 32826966
    [Google Scholar]
  98. DiClemente R.J. Young A.M. Painter J.L. Wingood G.M. Rose E. Sales J.M. Prevalence and correlates of recent vaginal douching among African American adolescent females. J. Pediatr. Adolesc. Gynecol. 2012 25 1 48 53 10.1016/j.jpag.2011.07.017 22051790
    [Google Scholar]
  99. Jayamurali D. Saminathan G. Varier K.M. Acharya P.S. Manoharan N. Parasuraman R. Revealing the hidden heights of microbial metabolites on reproductive physiology. Recent Advances and Future Perspectives of Microbial Metabolites Academic Press 2023 217 248 10.1016/B978‑0‑323‑90113‑0.00004‑3
    [Google Scholar]
  100. Minelli E.B. Benini A. Relationship between number of bacteria and their probiotic effects. Microb. Ecol. Health Dis. 2008 20 4 180 183
    [Google Scholar]
  101. Hanson L. VandeVusse L. Jermé M. Abad C.L. Safdar N. Probiotics for treatment and prevention of urogenital infections in women: A systematic review. J. Midwifery Womens Health 2016 61 3 339 355 10.1111/jmwh.12472 27218592
    [Google Scholar]
  102. Misra D.P. Trabert B. Atherly-Trim S. Variation and predictors of vaginal douching behavior. Womens Health Issues 2006 16 5 275 282 10.1016/j.whi.2006.03.005 17055380
    [Google Scholar]
  103. Brotman R.M. Klebanoff M.A. Nansel T.R. Andrews W.W. Schwebke J.R. Zhang J. Yu K.F. Zenilman J.M. Scharfstein D.O. A longitudinal study of vaginal douching and bacterial vaginosis--A marginal structural modeling analysis. Am. J. Epidemiol. 2008 168 2 188 196 10.1093/aje/kwn103 18503038
    [Google Scholar]
  104. Gonzalez N.L. O’Brien K.M. D’Aloisio A.A. Sandler D.P. Weinberg C.R. Douching, talc use, and risk of ovarian cancer. Epidemiology 2016 27 6 797 802 10.1097/EDE.0000000000000528 27327020
    [Google Scholar]
  105. Brotman RM Ghanem KG Klebanoff MA Taha TE Scharfstein DO Zenilman JM The effect of vaginal douching cessation on bacterial vaginosis: A pilot study. Am. J. Obstet. Gynecol. 2008 198 6 628 10.1016/j.ajog.2007.11.043
    [Google Scholar]
  106. Heng L.S. Yatsuya H. Morita S. Sakamoto J. Vaginal douching in Cambodian women: Its prevalence and association with vaginal candidiasis. J. Epidemiol. 2010 20 1 70 76 10.2188/jea.JE20081046 20009371
    [Google Scholar]
  107. Ocaktan M.E. Baran E. Akdur R. Evaluation of habitual behavior related to genital hygiene in women living in a health care center area. Saudi Med. J. 2010 31 11 1251 1256 21063658
    [Google Scholar]
  108. Ness R.B. Soper D. Holley R.L. Peipert J. Randall H. Sweet R.L. Sondheimer S.J. Hendrix S.L. Hillier S.L. Amortegui A. Trucco G. Bass D.C. PID Evaluation and Clinical Health (PEACH) Study Investigators Douching and Endometritis. Sex. Transm. Dis. 2001 28 4 240 245 10.1097/00007435‑200104000‑00010 11318257
    [Google Scholar]
  109. Zeng X Zhang Y Zhang T Xue Y Xu H An R Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi’an: A cross-sectional study. Biomed. Res. Int. 2018 2018 10.1155/2018/9703754
    [Google Scholar]
  110. Pines H.A. Semple S.J. Strathdee S.A. Hendrix C.W. Harvey-Vera A. Gorbach P.M. Magis-Rodríguez C. Martinez G. Patterson T.L. Vaginal washing and lubrication among female sex workers in the Mexico-US border region: Implications for the development of vaginal PrEP for HIV prevention. BMC Public Health 2018 18 1 1009 10.1186/s12889‑018‑5946‑z 30107833
    [Google Scholar]
  111. von Glehn M.P. Sidon L. Machado E. Gynecological complaints and their associated factors among women in a family health-care clinic. J. Family Med. Prim. Care 2017 6 1 88 92 10.4103/2249‑4863.214982 29026756
    [Google Scholar]
  112. Luo L. Xu J.J. Wang G.X. Ding G.W. Wang N. Wang H.B. Vaginal douching and association with sexually transmitted infections among female sex workers in a prefecture of Yunnan Province, China. Int. J. STD AIDS 2016 27 7 560 567 10.1177/0956462415589044 26016725
    [Google Scholar]
  113. Esber A. Rao N. Norris A. Carr Reese P. Kandodo J. Nampandeni P. Jumbe E. Norris Turner A. Intravaginal practices and prevalence of sexual and reproductive tract infections among women in rural Malawi. Sex. Transm. Dis. 2016 43 12 750 755 10.1097/OLQ.0000000000000531 27835627
    [Google Scholar]
  114. Carter M. Gallo M. Anderson C. Snead M.C. Wiener J. Bailey A. Costenbader E. Legardy-Williams J. Hylton-Kong T. Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica. West Indian Med. J. 2013 62 1 56 61 24171329
    [Google Scholar]
  115. Masese L. McClelland R.S. Gitau R. Wanje G. Shafi J. Kashonga F. Ndinya-Achola J.O. Lester R. Richardson B.A. Kurth A. A pilot study of the feasibility of a vaginal washing cessation intervention among Kenyan female sex workers. Sex. Transm. Infect. 2013 89 3 217 222 10.1136/sextrans‑2012‑050564 23002190
    [Google Scholar]
  116. Güzel A.I. Kuyumcuoğlu U. Celik Y. Vaginal douching practice and related symptoms in a rural area of Turkey. Arch. Gynecol. Obstet. 2011 284 5 1153 1156 10.1007/s00404‑010‑1805‑6 21153831
    [Google Scholar]
  117. Hassan S. Chatwani A. Brovender H. Zane R. Valaoras T. Sobel J.D. Douching for perceived vaginal odor with no infectious cause of vaginitis: A randomized controlled trial. J. Low. Genit. Tract Dis. 2011 15 2 128 133 10.1097/LGT.0b013e3181fb4270 21263351
    [Google Scholar]
  118. Arslantas D. Karabagli H. Koc F. Vaginal douching practice in Eskisehir in Turkey. J. Public Health Epidemiol. 2010 2 9 245 250
    [Google Scholar]
  119. Mairiga A.G. Kullima A.A. Kawuwa M.B. Social and health reasons for lime juice vaginal douching among female sex workers in Borno State, Nigeria. Afr. J. Prim. Health Care Fam. Med. 2010 2 1 1 4 10.4102/phcfm.v2i1.125
    [Google Scholar]
  120. McKee M.D. Baquero M. Anderson M.R. Alvarez A. Karasz A. Vaginal douching among Latinas: Practices and meaning. Matern. Child Health J. 2009 13 1 98 106 10.1007/s10995‑008‑0327‑3 18297379
    [Google Scholar]
  121. Hacıalioğlu N. Nazik E. Kılıç M. A descriptive study of douching practices in Turkish women. Int. J. Nurs. Pract. 2009 15 2 57 64 10.1111/j.1440‑172X.2009.01735.x 19335521
    [Google Scholar]
  122. Chen T Lin F Hou Y Application of lactobacillus crispatus in preparation of medicine for treating intrauterine adhesion. Patent CN115607578A, 2023
  123. Sun J Wang X Probiotic compound preparation and application thereof in regulation of vaginal flora and resistance to HPV. Patent CN112501051A, 2021
  124. Bradshaw C.S. Sobel J.D. Current treatment of bacterial vaginosis—limitations and need for innovation. J. Infect. Dis. 2016 214 Suppl 1 S14 S20 10.1093/infdis/jiw159 27449869
    [Google Scholar]
  125. Krebs-Bensch A Vaginal probiotic products and related processes. Patent US10258567B1, 2019
  126. Koenig DW Scholl NT Topolkaraev Va Heuvel ALV Protein stabilized probiotics and personal care products. Patent US2014065210A1, 2014
  127. Kaur IP Sharma G Probiotic formulation and uses thereof. Patent WO2019180748A1, 2019
  128. Castro IE Borquez YR Gonzales RM Aeschlimann AV Pharmaceutical composition including viable probiotic strains of lactobacillus spp. used for the prevention and recovery of individuals with urinary tract infections and immunocompromised individuals. Patent WO2011000124A1, 2011
  129. Chenoll CME Casinos RB Silva AA Ramon VD Genoves MS Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis. Patent US10588926B2, 2020
  130. Samuelsson C Weiner JA Kvanta E Lactic acid producing bacteria for use as probiotic organisms in the human vagina. Patent US2004253217A1, 2004
  131. Volkmann P-H Vaginal care composition. Patent US2005095232A1, 2005
  132. Bykov Va Dalin MV Kuz MEN Lactobacterium-Containing Suppository for Treatment of Patient with Vagina Dysbacteriosis. Patent RU2150268C1, 2000
  133. Cavaliere VRM De SC Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections. Patent EP0956858A1, 1999
  134. Simpson T. Merchant J. Grimley D.M. Kim Oh M. Vaginal douching among adolescent and young women: More challenges than progress. J. Pediatr. Adolesc. Gynecol. 2004 17 4 249 255 10.1016/j.jpag.2004.05.008 15288026
    [Google Scholar]
  135. Hawes S.E. Hillier S.L. Benedetti J. Stevens C.E. Koutsky L.A. Wølner-Hanssen P. Holmes K.K. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 1996 174 5 1058 1063 10.1093/infdis/174.5.1058 8896509
    [Google Scholar]
  136. Ness R.B. Hillier S.L. Kip K.E. Richter H.E. Soper D.E. Stamm C.A. McGregor J.A. Bass D.C. Rice P. Sweet R.L. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am. J. Epidemiol. 2005 161 2 186 195 10.1093/aje/kwi025 15632269
    [Google Scholar]
  137. Anstey Watkins J. Ross J.D.C. Thandi S. Brittain C. Kai J. Griffiths F. Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial. PLoS One 2019 14 11 e0224964 10.1371/journal.pone.0224964 31730666
    [Google Scholar]
  138. Plaza-Diaz J. Ruiz-Ojeda F.J. Gil-Campos M. Gil A. Mechanisms of action of probiotics. Adv. Nutr. 2019 10 Suppl. 1 S49 S66 10.1093/advances/nmy063 30721959
    [Google Scholar]
  139. Mendling W. Vaginal Microbiota. Adv. Exp. Med. Biol. 2016 902 83 93 10.1007/978‑3‑319‑31248‑4_6 27161352
    [Google Scholar]
  140. Ma D. Chen Y. Chen T. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: A conceptual analysis. FEMS Microbiol. Lett. 2019 366 4 fnz025 10.1093/femsle/fnz025 30715301
    [Google Scholar]
  141. Mikamo H. Sato Y. Hayasaki Y. Hua Y.X. Tamaya T. Vaginal microflora in healthy women with Gardnerella vaginalis. J. Infect. Chemother. 2000 6 3 173 177 10.1007/s101560070018 11810560
    [Google Scholar]
  142. Babu G. Singaravelu B.G. Srikumar R. Reddy S.V. Kokan A. Comparative study on the vaginal flora and incidence of asymptomatic vaginosis among healthy women and in women with infertility problems of reproductive age. J. Clin. Diagn. Res. 2017 11 8 DC18 DC22 10.7860/JCDR/2017/28296.10417 28969122
    [Google Scholar]
  143. Petrova M.I. van den Broek M. Balzarini J. Vanderleyden J. Lebeer S. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol. Rev. 2013 37 5 762 792 10.1111/1574‑6976.12029 23789590
    [Google Scholar]
  144. Pendharkar S. Skafte-Holm A. Simsek G. Haahr T. Lactobacilli and their probiotic effects in the vagina of reproductive age women. Microorganisms 2023 11 3 636 10.3390/microorganisms11030636 36985210
    [Google Scholar]
  145. Abbasi A. Aghebati-Maleki L. Homayouni-Rad A. The promising biological role of postbiotics derived from probiotic Lactobacillus species in reproductive health. Crit. Rev. Food Sci. Nutr. 2022 62 32 8829 8841 10.1080/10408398.2021.1935701 34152234
    [Google Scholar]
  146. Abbasi A. Rad A.H. Ghasempour Z. Sabahi S. Kafil H.S. Hasannezhad P. Rahbar Saadat Y. Shahbazi N. The biological activities of postbiotics in gastrointestinal disorders. Crit. Rev. Food Sci. Nutr. 2022 62 22 5983 6004 10.1080/10408398.2021.1895061 33715539
    [Google Scholar]
  147. Homayouni Rad A. Aghebati Maleki L. Samadi Kafil H. Fathi Zavoshti H. Abbasi A. Postbiotics as promising tools for cancer adjuvant therapy. Adv. Pharm. Bull. 2020 11 1 1 5 10.34172/apb.2021.007 33747846
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010322564240929204907
Loading
Bridging the GAP: Probiotic Douches Redefining the Feminine Hygiene
Bentham Science Publishers ; https://doi.org/10.2174/0113892010322564240929204907
/content/journals/cpb/10.2174/0113892010322564240929204907
/content/journals/cpb/10.2174/0113892010322564240929204907
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Vaginal health ; Douches ; Probiotics

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test